e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Tuberculosis: epidemiology and public health management II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immuno-allergic reactions to antituberculosis treatment
S. Habibech, H. Racil, S. Hfaidh, S. Cheikhrouhou, N. Chaouch, A. Chabbou (Ariana, Tunisia)
Source:
Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Session:
Tuberculosis: epidemiology and public health management II
Session type:
Thematic Poster Session
Number:
4458
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Habibech, H. Racil, S. Hfaidh, S. Cheikhrouhou, N. Chaouch, A. Chabbou (Ariana, Tunisia). Immuno-allergic reactions to antituberculosis treatment. Eur Respir J 2013; 42: Suppl. 57, 4458
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Pulmonary aspergilloma
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Aspects of TB endemia in Bucharest
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Acute phase reaction in pulmonary tuberculosis during treatment
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
High mortality from tuberculosis in Denmark
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Alternative surgical treatment for tuberculous cavern grafted by micosis
Source: Annual Congress 2013 –Surgery for pleuropulmonary and mediastinal benign diseases
Year: 2013
Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Importance of immunostimulation for community acquired pneumonia management
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
The lung surgery for HIV-positive patients
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Spectrum of urogenital tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Drug resistance among new TB cases in some Russian regions
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Use of delamanid for M/XDR-TB treatment under programmatic conditions in Latvia
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Progress of treatment delayed testicular tuberculosis: One case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Side effects of tuberculosis treatment with fixed-dose combinations
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Evaluation of adherence to tuberculosis screening in children
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
The impact of immunodeficiency diseases on tuberculosis infection in North East of Romania
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
Trends of MBT drug resistance
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Opportunistic infections in patients with lung tuberculosis
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept